🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

7,387 results for “Le” Clear

  1. D-CURE 25000 UI gélules., Placebo of vitamin D

    Laboratoire HRA Pharma

    Periodontitis

    approved small molecule active

    1 trial

  2. DABIGATRAN ETEXILATE , CLOPIDOGREL , RIVAROXABAN , APIXABAN , ACENOCOUMAROL , EDOXABAN

    The George Institute

    patients who are requested a colonoscopy for any indication and are under antiplatelet treatment (except ASA) or anticoagulant treatment

    approved small molecule active

    1 trial

  3. DOBUTAMINE , LEVOSIMENDAN

    The George Institute

    Heart failure patients with depressed left ventricular ejection fraction

    approved small molecule active

    1 trial

  4. Dabigatran Etexilate

    The First People's Hospital of Lianyungang

    Atrial Fibrillation

    approved small molecule active

    1 trial

  5. Danhong injection

    BRIGHT MINDS BIOSCIENCES INC.

    Unstable Angina Pectoris

    approved small molecule completed

    1 trial

  6. Danlou Tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease(CAD)

    approved small molecule active

    1 trial

  7. Dapagliflozin 10 MG

    The First People's Hospital of Lianyungang

    Type 2 Diabetes Mellitus

    approved small molecule active

    1 trial

  8. Daphnetin

    The First People's Hospital of Lianyungang

    Lower Extremity Lymphedema

    approved small molecule active

    1 trial

  9. De-escalated Dual Antiplatelet Therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease

    approved small molecule completed

    1 trial

  10. Deltius 50.000 UI cápsulas duras. Colecalciferol (Vitamina D3), CALCIFEDIOL

    Lacuna Pharma Pty Ltd

    Severe vitamin D deficiency

    approved small molecule active

    1 trial

  11. Dengzhan Shengmai capsule

    Universal Integrated

    Stroke

    approved small molecule completed

    1 trial

  12. Denominación Común Internacional (DCI): placebo (Suero fisiológico) Denominación Química: Cloruro Sódico 0.9% Forma molecular: NaCl Composición cuali y cuantitativa: 9mg/ml Forma farmacéutica: solución para pulverización nasal Dosis y vía de administración: 0.6ml/ día (6 pulverizaciones ) vía intranasa, Syntocinon 40 U.I./ml Solução para pulverização nasal

    The George Institute

    Borderline Personality Disorder.

    approved small molecule active

    1 trial

  13. Dental foam "Biorepair PERIBIOMA"

    The First People's Hospital of Lianyungang

    Oral Health

    approved small molecule completed

    1 trial

  14. Desmopressin

    The First People's Hospital of Lianyungang

    Patients Undergoing Endoscopic Sinus Surgery

    approved small molecule completed

    1 trial

  15. Deutetrabenazine Oral Capsule

    Teva Pharma GmbH

    Tardive Dyskinesia

    approved small molecule active

    1 trial

  16. Dex-Esk

    The First People's Hospital of Lianyungang

    Older Patients

    approved small molecule active

    1 trial

  17. Dexamethasone

    The First People's Hospital of Lianyungang

    Pancreatic Cancer

    approved small molecule active

    1 trial

  18. Dexamethasone

    The First People's Hospital of Lianyungang

    Carcinoma, Non-Small-Cell Lung

    approved small molecule terminated

    1 trial

  19. Dexamethasone 4 mg tablets, Dexamethasone Phosphate 4 mg/ml Solution for Injection

    Disc Medicine

    Solid tumors

    approved small molecule active

    1 trial

  20. Dexlansoprazole

    Takeda

    Gastroesophageal Reflux Disease

    approved small molecule completed

    4 trials

  21. Dexlansoprazole 60 MG

    Takeda

    GERD

    approved small molecule completed

    1 trial

  22. Dexmedetomidine

    The First People's Hospital of Lianyungang

    Obstructive Sleep Apnea

    approved small molecule completed

    1 trial

  23. Dexmedetomidine

    The First People's Hospital of Lianyungang

    Elderly

    approved small molecule completed

    3 trials

  24. Dexmedetomidine

    The First People's Hospital of Lianyungang

    Breast Cancer

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources